FOXP3 and neoplasm: In further examination of differences in the tumor microenvironment between sexes, Yu et al. (2024) found that untreated NSCLC tumors in female patients exhibited higher expression of CD4, CD4/FOXP3, and CD4/FOXP3/PD-L1 than tumors from male patients [63].